Retraction: Let-7a functions as a tumor suppressor in ewing's sarcoma cell lines partly by targeting cyclin-dependent kinase 6 (DNA and Cell Biology 33:3 (136-147) DOI: 10.1089/dna.2013.2179);Let-7a functions as a tumor suppressor in Ewing's sarcoma cell lines partly by targeting cyclin-dependent kinase 6

DNA and Cell Biology

Volumn 33, Issue 3, 2014, Pages 136-147

  Zhang, Zhongzu ^a   Huang, Lu ^b   Yu, Zhiming ^a   Chen, Xiang ^a   Yang, Dong ^a   Zhan, Ping ^a   Dai, Min ^a   Huang, Shanhu ^a   Han, Zhimin ^a   Cao, Kai ^a  

^a NANCHANG UNIVERSITY   (China)

^b Jiangxi Maternal and Child Health Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 6; LET 7A PROTEIN; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; EWING SARCOMA; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 6; DNA PRIMERS; DOWN-REGULATION; G1 PHASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; POLYMERASE CHAIN REACTION; SARCOMA, EWING;

EID: 84895725464     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2179.retract     Document Type: Erratum

References (33)

1. Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
2. Borinstein, S.C., Beeler, N., Block, J.J., Gorlick, R., Grohar, P., Jedlicka, P., et al. (2013). A Decade in Banking Ewing Sarcoma: a Report from the Children's Oncology Group. Front Oncol 3, 57.
3. Dauphinot, L., De Oliveira, C., Melot, T., Sevenet, N., Thomas, V., Weissman, B.E., et al. (2001). Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene 20, 3258-3265.
4. De Vito, C., Riggi, N., Suva, M.L., Janiszewska, M., Horlbeck, J., Baumer, K., et al. (2011). Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development. PLoS One 6, e23592.
5. Dong, Q., Meng, P., Wang, T., Qin, W., Wang, F., Yuan, J., et al. (2010). MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2. PLoS One 5, e10147.
6. Dylla, L., Moore, C., and Jedlicka, P. (2013). MicroRNAs in Ewing sarcoma. Front Oncol 3, 65.
7. Engels, B.M., and Hutvagner, G. (2006). Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 25, 6163-6169.
8. Feng, L., Xie, Y., Zhang, H., and Wu, Y. (2012). miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol 29, 856-863.
9. Grossel, M.J., and Hinds, P.W. (2006a). Beyond the cell cycle: a new role for Cdk6 in differentiation. J Cell Biochem 97, 485-493.
10. Grossel, M.J., and Hinds, P.W. (2006b). From cell cycle to differentiation: an expanding role for cdk6. Cell Cycle 5, 266-270.
11. Hirai, Y., Utsugi, K., Takeshima, N., Kawamata, Y., Furuta, R., Kitagawa, T., et al. (2004). Putative gene loci associated with carcinogenesis and metastasis of endocervical adenocarcinomas of uterus determined by conventional and array-based CGH. Am J Obstet Gynecol 191, 1173-1182.
12. Huang, H.J., Angelo, L.S., Rodon, J., Sun, M., Kuenkele, K.P., Parsons, H.A., et al. (2011). R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/ Akt axis. PLoS One 6, e26060.
13. Iorio, M.V., Casalini, P., Piovan, C., Braccioli, L., and Tagliabue, E. (2011). Breast cancer and microRNAs: therapeutic impact. Breast 20 Suppl 3, S63-S70.
14. Iwamoto, Y. (2007). Diagnosis and treatment of Ewing's sarcoma. Jpn J Clin Oncol 37, 79-89.
15. Johnson, C.D., Esquela-Kerscher, A., Stefani, G., Byrom, M., Kelnar, K., Ovcharenko, D., et al. (2007). The let-7 micro- RNA represses cell proliferation pathways in human cells. Cancer Res 67, 7713-7722.
16. Kala, R., Peek, G.W., Hardy, T.M., and Tollefsbol, T.O. (2013). MicroRNAs: an emerging science in cancer epigenetics. J Clin Bioinforma 3, 6.
17. Kim, S.J., Shin, J.Y., Lee, K.D., Bae, Y.K., Sung, K.W., Nam, S.J., et al. (2012). MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7. Breast Cancer Res 14, R14.
18. Kozar, K., and Sicinski, P. (2005). Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle 4, 388-391.
19. Lu, L., Katsaros, D., de la Longrais, I.A., Sochirca, O., and Yu, H. (2007). Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 67, 10117-10122.
20. Lu, L., Katsaros, D., Zhu, Y., Hoffman, A., Luca, S., Marion, C.E., et al. (2011). Let-7a regulation of insulin-like growth factors in breast cancer. Breast Cancer Res Treat 126, 687-694.
21. Nagel, S., Leich, E., Quentmeier, H., Meyer, C., Kaufmann, M., Drexler, H.G., et al. (2008). Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma. Leukemia 22, 387-392.
22. Philippe, L., Alsaleh, G., Bahram, S., Pfeffer, S., and Georgel, P. (2013). The miR-17 approximately 92 Cluster: a key player in the control of inflammation during rheumatoid arthritis. Front Immunol 4, 70.
23. Ruas, M., Gregory, F., Jones, R., Poolman, R., Starborg, M., Rowe, J., et al. (2007). CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms. Mol Cell Biol 27, 4273-4282.
24. Schwabe, R.F., and Wang, T.C. (2011). Targeting liver cancer: first steps toward a miRacle? Cancer Cell 20, 698-699.
25. Sun, X., Qin, S., Fan, C., Xu, C., Du, N., and Ren, H. (2013). Let- 7: a regulator of the ERalpha signaling pathway in human breast tumors and breast cancer stem cells. Oncol Rep 29, 2079-2087.
26. Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64, 3753-3756.
27. Tsai, J.W., Li, C.F., Kao, Y.C., Wang, J.W., Fang, F.M., Wang, Y.H., et al. (2012). Recurrent amplification at 7q21.2 Targets, CD.K6 gene in primary myxofibrosarcomas and identifies CDK6 overexpression as an independent adverse prognosticator. Ann Surg Oncol 19, 2716-2725.
28. Vasudevan, S., Tong, Y., and Steitz, J.A. (2007). Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931-1934.
29. Wang, Y., Hu, X., Greshock, J., Shen, L., Yang, X., Shao, Z., et al. (2012). Genomic, DN.A copy-number alterations of the let-7 family in human cancers. PLoS One 7, e44399.
30. Wang, Y.Y., Ren, T., Cai, Y.Y., and He, X.Y. (2013). MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression. Cancer Biother Radiopharm 28, 131-137.
31. Wiedemeyer, W.R., Dunn, I.F., Quayle, S.N., Zhang, J., Chheda, M.G., Dunn, G.P., et al. (2010). Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM. Proc Natl Acad Sci U S A 107, 11501- 11506.
32. Yanokura, M., Banno, K., Kobayashi, Y., Kisu, I., Ueki, A., Ono, A., et al. (2010). MicroRNA and endometrial cancer: roles of small RNAs in human tumors and clinical applications (Review). Oncol Lett 1, 935-940.
33. Zhan, S., Shapiro, D.N., and Helman, L.J. (1995). Loss of imprinting of IGF2 in Ewing's sarcoma. Oncogene 11, 2503- 2507.